CJC-1295 (No DAC)

Return to Home

Advanced Metabolic Peptide

CJC-1295 (No DAC)

  • Supports investigation of pulsatile growth hormone signaling patterns
  • Enables controlled study of transient receptor activation mechanisms
  • Assists in analyzing somatotropic axis regulatory dynamics
  • Contributes to endocrine pathway timing and modulation research
  • Facilitates deeper understanding of GHRH analogue receptor interactions

Product Overview

CJC-1295 (No DAC) is a synthetic analogue of growth hormone–releasing hormone (GHRH) designed without the Drug Affinity Complex (DAC) component, resulting in a shorter half-life profile in research models. Within controlled laboratory environments, it is investigated for its role in regulated growth hormone signaling and pulsatile endocrine modulation studies.

Due to its reduced duration of receptor engagement compared to DAC-modified variants, CJC-1295 (No DAC) is commonly examined in experimental frameworks evaluating receptor-mediated signaling dynamics, transient pathway activation, and somatotropic axis regulation under precisely timed research conditions.

At Nexzya Bioscience, CJC-1295 (No DAC) is manufactured under strict research-grade protocols. Each batch undergoes advanced analytical verification to confirm peptide identity, structural accuracy, and purity standards. Our laboratory maintains rigorous quality control processes to ensure reproducibility, traceability, and precision for endocrine and receptor-focused research applications.

Key Characteristics

  • Synthetic analogue of growth hormone–releasing hormone (GHRH)

  • Formulated without Drug Affinity Complex (DAC)

  • Shorter half-life profile in experimental models

  • Precisely defined amino acid sequence

  • High-purity research-grade formulation

  • Molecular identity validated through advanced analytical testing

  • Investigated in pulsatile endocrine signaling studies

  • Examined for receptor-mediated somatotropic pathway dynamics

  • Designed for controlled in vitro and pre-clinical laboratory research

  • Batch-specific analytical documentation and traceability available

Direct Research Applications & Potential Benefits

  • Supports investigation of pulsatile growth hormone signaling patterns

  • Enables controlled study of transient receptor activation mechanisms

  • Assists in analyzing somatotropic axis regulatory dynamics

  • Contributes to endocrine pathway timing and modulation research

  • Facilitates deeper understanding of GHRH analogue receptor interactions

Final Overview

CJC-1295 (No DAC) from Nexzya Bioscience reflects our commitment to analytical rigor, peptide precision, and research integrity. Developed exclusively for laboratory investigation, this compound adheres to stringent purity and quality validation standards to ensure consistent performance across advanced endocrine research models.

For laboratories requiring precisely characterized short-acting GHRH analogues, Nexzya Bioscience delivers research-grade solutions built on scientific reliability and methodological excellence.

Request Technical Information

To receive detailed analytical reports, batch specifications, and technical documentation for CJC-1295 (No DAC), please complete the form below with your name and email.

Our scientific team will provide comprehensive information aligned with your laboratory research objectives.

Advanced Peptide Science & Biomolecular Research

South Korea — 대한민국
Czech Republic — Česká republika

Resources

NEXZYA™ Bioscience | Since 1986 All Rights Reserved